Researchers at the National Institutes of Health (NIH) and Oregon Health & Science University (OHSU) have found that an experimental vaccine elicits antibodies that can protect nonhuman primates from Ebola virus infection. Ebola virus causes severe hemorrhagic fever in humans and nonhuman primates, meaning that infection may lead to shock, bleeding and multi-organ failure. According to the World Health Organization, Ebola hemorrhagic fever has a fatality rate of up to 90 percent. There is no licensed treatment or vaccine for Ebola virus infection.
Several research groups have developed experimental vaccine approaches that protect nonhuman primates from Ebola virus and the closely related Marburg virus. These approaches include vaccines based on DNA, recombinant adenovirus, virus-like particles, and human parainfluenza virus 3. But how these vaccine candidates confer protection is an area that is still being explored: Do they activate immune cells to kill the invading virus? Or do they elicit antibodies that block infection?
In this study, scientists at NIH's National Institute of Allergy and Infectious Diseases and OHSU's Vaccine & Gene Therapy Institute built on earlier work with an experimental vaccine composed of an attenuated vesicular stomatitis virus carrying a gene that codes for an Ebola virus protein. They observed how cynomolgus macaques responded to a challenge of Ebola virus before and during treatment with the vaccine and in conjunction with depleted levels of immune cells. Their results showed that important immune cells—CD4+ T cells and CD8+ T cells—had a minimal role in providing protection, while antibodies induced by the vaccine appeared to be critical to protecting the animals.
The scientists say this finding will help improve future Ebola virus vaccine development. They plan to focus their studies on what level of antibody production is needed to establish protection from Ebola virus infection in humans
WHO: Heinz Feldmann, M.D., Ph.D., chief of the Laboratory of Virology at NIAID's Rocky Mountain Laboratories. Dr. Feldmann is an expert on viral hemorrhagic fevers and emerging viruses.
ARTICLE: A Marzi et al. Antibodies are necessary for rVSV/ZEBOV-GP mediated protection against lethal Ebola virus challenge in nonhuman primates. Proceedings of the National Academy of Sciences. DOI: 10.1073/pnas.1209591110 (2013).
NIH/National Institute of Allergy and Infectious Diseases: http://www.niaid.nih.gov
This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
A bulletin posted today from NOAA stated that the climate event known as El Niño has a 50 percent chance of returning this summer or fall. If it appears, it could mean heavy rainfall next winter for drought-stricken California and ...
Elephants that give birth as teenagers die younger, but are fitter than mothers that delay, scientists say.
National and state parks in California are under threat from burl wood seekers.
A new study concludes that 136 UNESCO World Heritage sites could be washed away by rising sea levels
The park's bears have developed a taste for human food, and that's gotten them in big trouble. But efforts to teach campers to lock up food are helping solve the problem, a bear hair analysis shows.
A "live fast, die young" life history strategy could have played a key role leading to the high tree diversity in the Amazon, scientists suggest.
Scientists using satellite tracking finally have some data on where very young loggerhead turtles go once they leave Florida and the Gulf of Mexico.
Europe's manufacturers would see profits rise by €100 billion a year if they used fewer resources and recycled more
Antarctica is one of the most pristine environments on Earth, but it’s wrestling with a pollution problem.
Indonesia's senior Muslim clerics issue first ever fatwa against wildlife smuggling and challenge the country's 200 million Muslims to protect threatened wildlife.